Bloomberg
-
Coronavirus Treatment: Antibodies and the Race for a Vaccine
May.04 — Takeda President of Global Business Rajeev Venkayya discusses efforts among companies and nations to develop a coronavirus vaccine and the importance of making the vaccine available to the…
-
Nobel Laureate Doherty on Coronavirus, Lockdowns, Vaccines
May.03 — Peter Doherty, a researcher who won a Nobel Prize in Physiology or Medicine in 1996 for discovering how the immune system recognizes virus-infected cells, talks about the covid-19.…
-
Australia’s Call for Virus Probe Stokes Tensions With China
May.03 — Geoff Raby, former Australian Ambassador to China and now chairman of Geoff Raby & Associates, discusses the bilateral relations between the two governments amid the coronavirus outbreak. Australia’s…
-
U.S. Is Not Pursuing a Virus “Strategy With Rational Foundation,” Says Summers
May.01 — Lawrence H. Summers, former U.S. Treasury Secretary, warns that U.S. Leadership in reopening the economy is too optimistic because conditions required to return to normalcy have not been…
-
Coronavirus Special Report: Medicine’s Critical Challenge
May.01 — From vaccine development, to more accurate testing, to measures that limit contagion and improve treatment outcomes, medicine is playing a central role in combating the COVID-19 coronavirus. Interviews…
-
U.S. is not pursuing “strategy with a rational foundation” in dealing with outbreak: Summers
May.01 — Lawrence H. Summers, former U.S. Treasury Secretary, warns that U.S. Leadership in reopening the economy is too optimistic because conditions required to return to normalcy have not been…
-
“Coronavirus: Medicine’s Critical Challenge” Special
May.01 — From vaccine development, to more accurate testing, to measures that limit contagion and improve treatment outcomes, medicine is playing a central role in combating the COVID-19 coronavirus. Interviews…
-
PJT Partners’ Coleman on Virus Bankruptcies, Restructuring, High-Yield
May.01 — Tim Coleman, global chairman of the restructuring and special situations group at PJT Partners, discusses the likelihood of increased corporate bankruptcies due to the financial impact of the…
-
Drugs & Vaccines That Might End the Coronavirus
May.01 — More than 200 different programs have been launched to develop vaccines and therapeutics to combat Covid-19. From well-known industry giants such as Gilead Sciences Inc. to Johnson &…
-
U.S. Coronavirus Cases Increase at Slowest Pace in a Month
May.01 — U.S. coronavirus cases recorded the slowest daily increase for the month of April. Meanwhile, President Donald Trump will travel to Camp David, his first time leaving the White…